Internal Medicine Doctors in Dundalk, MD Accepting Medicare
4 Internal Medicine doctors found. Showing 1 - 4
 Cathy L Stanfield, NP Internal Medicine - Addiction Medicine Medicare: May Accept Medicare Assignments Practice Location: 40 S Dundalk Ave Ste 400, Dundalk, MD 21222 Phone: 410-220-0720 |
Mrs. Savinder Kaur Julka, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Market Place, Dundalk, MD 21222 Phone: 410-284-1800 Fax: 410-284-3275 |
 Dr. Raymond John Altieri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 314 German Hill Rd, Dundalk, MD 21222 Phone: 410-285-1000 Fax: 410-284-1961 |
Krina Patel, Internal Medicine Medicare: Medicare Enrolled Practice Location: 207 Wise Ave, Dundalk, MD 21222 Phone: 410-284-1004 |
News Archive
Discovery of a gene-expression signature common to distinct types of cancer
Researchers at the University of Michigan, Johns Hopkins and the Institute of Bioinformatics in India have discovered a gene-expression "signature" common to distinct types of cancer
New data from KYTHERA Biopharmaceuticals' ATX-101 studies on double chin
KYTHERA Biopharmaceuticals, Inc. today announced four abstracts will be presented at the 71st American Academy of Dermatology (AAD) Annual Meeting in Miami Beach, Fla.
Study examines the effectiveness of using virtual reality to train healthcare providers in empathy
Research has shown empathy gives healthcare workers the ability to provide appropriate supports and make fewer mistakes. This helps increase patient satisfaction and enhance patient outcomes, resulting in better overall care.
New cancer detection technology from Rubicon Genomics
Rubicon Genomics has invented a more effective technology for the diagnosis and prognosis of cancer compared to what hospitals and reference laboratories use today. MethylPlex™ is the most sensitive method in use to detect the patterns of abnormal DNA methylation arising in the serum and urine of patients during tumor formation and progression.
Koronis' KP-1461 drug causes extra mutations to occur in HIV genome in HIV-infected patients
Recently published Phase 2a clinical trial results show that the frequency of specific, drug-induced mutations in the HIV genome can be significantly increased by administering KP-1461, a drug being developed by Koronis Pharmaceuticals based on its novel Viral Decay Acceleration (VDA) drug mechanism.
› Verified 2 days ago
Internal Medicine
Psychiatry & Neurology
Pediatrics
Family Medicine
Surgery